News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Clovis Oncology (CLVS) and AstraZeneca PLC (AZN) Duke it Out Over Lung and Ovarian Cancer Drugs     10/5/2015
Top 10 Best-Selling Biotech Drugs     10/2/2015
Troubled XOMA  (XOMA) Nails Immuno-Oncology Pact Worth $530 Million+ With Novartis AG (NVS)     10/2/2015
Third Rock Ventures Leads Formation of Neon Therapeutics with $55 Million Series A Round     10/2/2015
Verastem (VSTM) Stops Study of Experimental Cancer Therapy; Stock Plunges     9/29/2015
Novartis AG (NVS)'s Top Scientist to Step Down, Taps Harvard Medical School Faculty Member to Drive Oncology Research     9/28/2015
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
Turing Pharma Not Justified in Increasing Daraprim Price by 5,000 Percent, BioSpace Readers Say     9/25/2015
Turing Pharma Becomes Political Football, Donald Trump Weighs In     9/25/2015
Outcry Forces Turing Pharma to Reduce Price Increase of Toxoplasmosis Drug     9/24/2015
In Face of Multiple Patent Cliffs, Amgen (AMGN) Expands Cancer Drugs Portfolio     9/22/2015
Akari, Deciphera Both Nab $75 Million in Financing     9/21/2015
Amgen (AMGN) Deal Brings Xencor $45M Up Front, Setup for $1.7B in Milestones     9/16/2015
Genentech (RHHBY) to Present Data from 15 Oncology Studies at European Cancer Congress     9/8/2015
AstraZeneca PLC (AZN) And Starpharma Ink Drug Delivery Deal Worth up to $450 Million     9/8/2015

News from Around the Web
Cancer Drug Appears To Sharpen Memory Too, Rutgers, The State University Of New Jersey Study     10/6/2015
Researchers Discover Link Between Height And Cancer, Karolinska Institute Study     10/2/2015
New Portable Device Counts Leukocytes Through The Skin, MIT Study     10/1/2015
Sniffing Out Cancer With Improved "Electronic Nose" Sensors, Nano Letters Reveals     10/1/2015
Drugs Go Under Cover As Platelets To Destroy Cancer, North Carolina State University Study     9/30/2015
Eat Spicy, Live Longer? Study Says Yes, Tulane University Reveals     9/29/2015
A Blood Test For Early Cancer Detection Sparks Debate     9/29/2015
Pregnant Cancer Patients Shouldn't Terminate Or Delay Treatment: Study     9/28/2015
Post Diagnosis Aspirin Improves Survival In All Gastrointestinal Cancers, Leiden University Medical Center Study     9/28/2015
Surgical Probe Seeks Out Where Cancer Ends And Healthy Tissue Begins, University of Illinois Study     9/28/2015
Cancer-Screening Tool From Racine Company "Going To Save Lives," Vista Dental Products Reveals     9/28/2015
Female Mice Exposed To Environmental Chemicals May Cause Decreased Physical Activity In Their Offspring, University of Missouri Study     9/23/2015
12 Cancer-Causing Chemicals to Banish From Your Life     9/22/2015
One Biotech CEO's Plan To Slash The Cost Of Cancer Immunotherapy     9/18/2015
Launching Saliva Detection Test For Oral Cancer, Perirx Sees Opportunity For Early-Stage Disease Dx     9/16/2015

Press Releases
Ascend Announces Patients With Nodular Basal Cell Carcinoma Receives First Dose Of ASN-002 In Phase 1/2a Study     10/7/2015
Can-Fite BioPharma (CFBI) To Deliver 2 Presentations On Its Cancer Drug CF102 At The 20th World Congress On Advances In Oncology And 18th International Symposium On Molecular Medicine On October 8-10, 2015 In Athens     10/7/2015
Avant Diagnostics Receives FDAIRB Approval for OvaDx Ovarian Cancer Validation Test Specimens     10/7/2015
Vaccinogen Appoints Michael G. Hagerman To Its Board Of Directors     10/6/2015
Affimed Therapeutics AG (AFMD) To Present Data On Potency Of NK- And T-Cell Egfrviii Tandabs At SITC     10/6/2015
bioTheranostics Announces Collaboration With DeNovo Sciences To Evaluate Its Proprietary Cancer Biomarkers For Use In Liquid Biopsies     10/6/2015
Varian Medical Systems (VAR) Inks Licensing Deal With Fraunhofer For Novel Multi-Criteria Optimization (MCO) Tool For Radiotherapy Treatment Planning     10/6/2015
Oncobiologics Announces ONS-1045 (Avastin/bevacizumab biosimilar) Meets Primary And Secondary Endpoints In Phase 1 Clinical Trial     10/5/2015
f-Star Announces Publication In Molecular Therapy Of Preclinical Data Evaluating Its Lead Compound FS102 For The Treatment Of HER2-Positive Cancers     10/5/2015
Data At SITC Annual Meeting To Highlight Progress Of Incyte (INCY)’s Immuno-Oncology Portfolio     10/2/2015
Kite Pharma (KITE) Announces Peer-Reviewed Publication Of T Cell Receptor Based Product Candidate To Treat HPV-Associated Cancers     10/1/2015
Pharmatech, Inc. And Cure Forward To Accelerate Oncology Clinical Trial Enrollment     10/1/2015
CTI BioPharma And Fred Hutchinson Cancer Research Center Announce International Research Fellowship To Support Innovative Blood-Related Cancer Research     10/1/2015
Amoy Diagnostics, Illumina (ILMN) Team Up to Discover Next-Gen Sequencing Cancer Diagnostics in China     10/1/2015
Counsyl Offers Free Genetic Cancer Screening To All Women In San Francisco Bay Area Through Collaboration With Bright Pink And University of California, San Francisco (UCSF)     10/1/2015